POC - Atopic dermatitis
ClinicalTrials.gov NCT05018806
Research payments
$611,051
Through program year 2024, $611,051 in research payments was reported against POC - Atopic dermatitis, across 55 payments, paid by Genzyme Corporation.
- Paid by
- Genzyme Corporation
- ClinicalTrials.gov
- NCT05018806
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $24,541 | 4 |
| 2023 | Research | $259,322 | 23 |
| 2022 | Research | $315,488 | 26 |
| 2021 | Research | $11,700 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Cindy Owen Louisville, KY Named on 13 payments
- Elena Valor Miami, FL Named on 11 payments
- Leon Kircik Louisville, KY Named on 9 payments
- William Howland Austin, TX Named on 6 payments
- Luke Webb Colorado Springs, CO Named on 4 payments
- Patricia Gerber North Charleston, SC Named on 4 payments
- Neal Bhatia San Diego, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.